View in EDS HTML Full Text PDF Full Text

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol.

Saved in:
Bibliographic Details
Title: Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol.
Authors: Freet CS; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA., Shuler K; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA., Kawasaki S; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA.; Pennsylvania Psychiatric Institute, Penn State Health, Harrisburg, PA, USA.; Department of Medicine, Penn State College of Medicine, Hershey, PA, USA., Weintraub E; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Greenblatt A; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Kladney M; Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.; Bellevue Hospital Center, New York, NY, USA., Nunes E; Division of Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA., Foster KL; National Institute on Drug Abuse, Bethesda, MD, USA., Kong L; Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA., Raja-Khan N; Department of Medicine, Penn State College of Medicine, Hershey, PA, USA., Cleveland HH; Department of Human Development and Family Studies, Pennsylvania State University, University Park, PA, USA., Grigson PS; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA., Bunce SC; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA., Brick TR; Department of Human Development and Family Studies, Pennsylvania State University, University Park, PA, USA.; Institute for Computational and Data Sciences, Pennsylvania State University, University Park, PA, USA., Nyland JE; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA. jnyland@pennstatehealth.psu.edu.
Source: Addiction science & clinical practice [Addict Sci Clin Pract] 2025 Oct 30; Vol. 20 (1), pp. 89. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101316917 Publication Model: Electronic Cited Medium: Internet ISSN: 1940-0640 (Electronic) Linking ISSN: 19400632 NLM ISO Abbreviation: Addict Sci Clin Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41168808
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freet+CS%22">Freet CS</searchLink>; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shuler+K%22">Shuler K</searchLink>; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA.<br /><searchLink fieldCode="AU" term="%22Kawasaki+S%22">Kawasaki S</searchLink>; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA.; Pennsylvania Psychiatric Institute, Penn State Health, Harrisburg, PA, USA.; Department of Medicine, Penn State College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Weintraub+E%22">Weintraub E</searchLink>; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Greenblatt+A%22">Greenblatt A</searchLink>; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kladney+M%22">Kladney M</searchLink>; Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.; Bellevue Hospital Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nunes+E%22">Nunes E</searchLink>; Division of Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Foster+KL%22">Foster KL</searchLink>; National Institute on Drug Abuse, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kong+L%22">Kong L</searchLink>; Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Raja-Khan+N%22">Raja-Khan N</searchLink>; Department of Medicine, Penn State College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cleveland+HH%22">Cleveland HH</searchLink>; Department of Human Development and Family Studies, Pennsylvania State University, University Park, PA, USA.<br /><searchLink fieldCode="AU" term="%22Grigson+PS%22">Grigson PS</searchLink>; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA.<br /><searchLink fieldCode="AU" term="%22Bunce+SC%22">Bunce SC</searchLink>; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Brick+TR%22">Brick TR</searchLink>; Department of Human Development and Family Studies, Pennsylvania State University, University Park, PA, USA.; Institute for Computational and Data Sciences, Pennsylvania State University, University Park, PA, USA.<br /><searchLink fieldCode="AU" term="%22Nyland+JE%22">Nyland JE</searchLink>; Department of Neuroscience and Experimental Therapeutics, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA. jnyland@pennstatehealth.psu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101316917%22">Addiction science & clinical practice</searchLink> [Addict Sci Clin Pract] 2025 Oct 30; Vol. 20 (1), pp. 89. <i>Date of Electronic Publication: </i>2025 Oct 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101316917 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1940-0640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219400632%22">19400632 </searchLink><i>NLM ISO Abbreviation: </i>Addict Sci Clin Pract <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41168808
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13722-025-00618-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 89
    Titles:
      – TitleFull: Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freet CS
      – PersonEntity:
          Name:
            NameFull: Shuler K
      – PersonEntity:
          Name:
            NameFull: Kawasaki S
      – PersonEntity:
          Name:
            NameFull: Weintraub E
      – PersonEntity:
          Name:
            NameFull: Greenblatt A
      – PersonEntity:
          Name:
            NameFull: Kladney M
      – PersonEntity:
          Name:
            NameFull: Nunes E
      – PersonEntity:
          Name:
            NameFull: Foster KL
      – PersonEntity:
          Name:
            NameFull: Kong L
      – PersonEntity:
          Name:
            NameFull: Raja-Khan N
      – PersonEntity:
          Name:
            NameFull: Cleveland HH
      – PersonEntity:
          Name:
            NameFull: Grigson PS
      – PersonEntity:
          Name:
            NameFull: Bunce SC
      – PersonEntity:
          Name:
            NameFull: Brick TR
      – PersonEntity:
          Name:
            NameFull: Nyland JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 10
              Text: 2025 Oct 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1940-0640
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Addiction science & clinical practice
              Type: main
ResultId 1